DGAP-News 179 0 Kommentare MPH Health Care AG: result Q1-2021 - Seite 2

In the trading segment, the operational optimization of the business activities of HAEMATO AG continued, which was able to report an increase in turnover in the past quarter compared to the previous year. In the process, HAEMATO AG was able to significantly improve its profitability. The share price of M1 Kliniken AG improved from 9.24 euros on 31 December 2020 to 10.85 euros on 31 March 2021.

Our second listed investment CR Capital AG (formerly CR Capital Real Estate AG) was also able to continue on its successful path in 2021 - almost unaffected by the COVID-19 pandemic - and continued to grow profitably. In the first three months, CR Capital was already able to notarially sell 161 residential units with a sales volume of approx. EUR 54 million in the projects Rousseau Park in the Berlin suburbs and Leipzig-Schkeuditz via participation Terrabau. The share price of CR Capital AG has increased from EUR 30.50 on 31 December 2020 to EUR 32.50 on 31 March 2021.

With an increasing easing of the Corona restrictions due to rising vaccination rates and falling case numbers, we are confident about the further development of our investments. All M1 Med Beauty locations in Germany and abroad have been reopened in the meantime, HAEMATO AG is making an important contribution to the Corona pandemic with the sale of medical products for Covid-19 diagnostics, and CR Capital AG has so far been able to record a continually strong demand for affordable residential real estate.

Due to the ongoing Corona pandemic, MPH Health Care AG will make use of the option to invite shareholders to the company's Annual General Meeting scheduled for 15 July 2021 with a shortened notice period of 21 days.

About MPH Health Care AG:
MPH AG is an investment company with a strategic focus on the purchase, development and sale of companies and company shares, especially in growth segments of the health care market. This includes both insurance-financed and privately financed segments. However, MPH also exploits potentials outside the healthcare market from high-growth and high-yield sectors.